TG Therapeutics: 'Strong Buy' On BRIUMVI's Massive Growth And Possible Expansion

2026-02-27 14:31:45 ET

The last time I spoke about TG Therapeutics ( TGTX ), it was with respect to a Seeking Alpha article entitled " TG Therapeutics: Another Possible Avenue Of MS Growth With Azer-Cel ." With respect to this article, I noted that the company was looking to expand its presence for the treatment of patients with multiple sclerosis [MS] with an allogeneic off-the-shelf CD-19 CAR T, known as Azer-Cel. That is, the goal is to use this to target patients with progressive multiple sclerosis [PMS]. An update for this program is expected to be provided by the company later this year. I had a "Strong Buy" rating the last time around, and I'm going to maintain this because the company has momentum on its side for starters....

Read the full article on Seeking Alpha

For further details see: